# Delve AI vs Unlearn.AI

Delve AI records 49,025 monthly visits with -4.6% month-over-month growth and Freemium pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

| Metric | [Delve AI](https://openaitools.app/tool/delve) | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) |
| :--- | :--- | :--- |
| Website URL | https://www.delve.ai | https://unlearn.ai |
| Categories | AI Research Tool, AI Marketing, AI Person Generator, AI Digital Marketing | AI Healthcare, AI Research Tool, AI Predictions, AI Models |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 49,025 | 17,107 |
| MoM Growth Rate | -4.6% | -32.5% |
| Primary Market | United States | United States |
| Direct Visits | 19,719 | 7,493 |
| Review Score | 4.3 | 4.4 |
| Saved Count | 7 | 1 |
| Supported Platforms | Website | Website |

## Delve AI

Delve AI starts where most research projects stall: turning scattered data into usable audience models. The platform pulls from first-party sources and public data sets, segments audiences automatically, and produces detailed personas and journey maps covering behaviors, preferences and decision stages. Those personas are not static documents — they become digital twins you can question any time through the browser or collaboration tools.

From there, the platform supports synthetic research. Instead of waiting weeks for recruitment and fieldwork, teams can run surveys, interviews, focus groups and UX tests against AI personas of their customers, including hard-to-reach segments, and get results in minutes. Pre-built studies cover common jobs such as creative testing, video testing, email testing and influencer ranking, so a team can validate messaging or a website concept without a full research cycle.

The Marketing Advisor layer converts those insights into action. It generates recommendations tailored to specific channels, updates as persona data changes, and gives marketers concrete campaign and content ideas rather than raw statistics. Delve AI is used by tens of thousands of brands and agencies, integrates with common data sources, and publishes case studies across construction, telecom and financial services.

**Pricing & Plans:** Delve AI follows a freemium model: you can start generating personas and exploring the platform for free, then move to paid plans for heavier usage, more studies and team features. Exact plan tiers and rates are listed on its pricing page, and demo calls are available for larger deployments.

- **Automated persona generator:** Build comprehensive customer, user, audience and employee personas from first-party and public data, with automatic segmentation and in-depth audience insights.
- **Digital twins:** Turn personas into interactive twins you can chat with 24/7 to test ideas, ask questions and make customer-centric decisions without scheduling interviews.
- **Synthetic research:** Run surveys, interviews, focus groups and UX tests against AI personas of your audience to get scalable, cost-effective results in minutes.
- **Marketing Advisor:** Receive channel-specific marketing and campaign recommendations derived from persona insights, with dynamic updates as your data evolves.
- **Journey maps and pre-built studies:** Visualize user, customer and employee journeys, and deploy ready-made studies for creative, video, email testing and influencer ranking.

**Strengths:** Automates persona creation that normally consumes weeks of manual research; Digital twins make personas interactive rather than static PDFs; Marketing Advisor turns insights into concrete channel-level recommendations; Freemium entry point lets teams test the value before paying

**Limitations:** Synthetic research is directional and should not fully replace talking to real people; Persona quality depends heavily on the quality and volume of data you connect; Serious use requires paid plans, and enterprise needs involve a sales conversation

[Profile (Markdown)](https://openaitools.app/tool/delve.md)

## Unlearn.AI

Unlearn.AI works with biopharma sponsors and clinical research teams at three points in a trial's lifecycle: before the protocol is finalized, while the study is running, and after readout. In design, teams model the patients they expect to enroll and pressure-test sample size, eligibility criteria, endpoints, and comparators before locking the protocol. The company's PROCOVA method — described as EMA-qualified and FDA-supported — applies twin-based covariate adjustment to reduce sample size in randomized controlled trials while holding statistical power, or to increase power without adding patients.

Mid-study, Unlearn supports pre-specified twin-based analyses that tighten interim estimates without enrolling anyone new, and lets teams re-run design scenarios when new evidence — a competitor readout, a fresh publication, or blinded data drifting from assumptions — changes the picture. After a study reads out, digital twins are used to contextualize population, endpoints, and variability, improving sensitivity across endpoints and helping teams re-evaluate historical trial data with regulatory-aligned methods.

Unlearn publishes concrete case outcomes: a 20% sample-size reduction built into a Phase 1/2 design with roughly $2M in savings, a 33% smaller control arm and four-plus months of enrollment time saved in a re-analysis of completed Phase 3 trials from a top-5 global sponsor, and a completed Phase 3 ALS trial re-analyzed to keep full power with 92 fewer participants. The company partners with sponsors including Trace Neuroscience, QurAlis, Acumen Pharmaceuticals, SOLA Biosciences, VectorY Therapeutics, and CHDI Foundation, and states it works with top global pharma companies. Unlearn does not publish list pricing; engagements are scoped through direct contact.

**Pricing & Plans:** Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

**Strengths:** Digital twins are generated from data already collected, so no extra patients are required to gain information; Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims; Covers the whole trial lifecycle: design, interim, and readout, not just one decision point; Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology

**Limitations:** Pricing is not published, so budgeting requires a direct sales conversation; The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication; Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool; Public metrics come from specific studies and may not transfer directly to other indications

[Profile (Markdown)](https://openaitools.app/tool/unlearn-ai.md)

## Frequently Asked Questions

### How do Delve AI and Unlearn.AI compare in monthly traffic?

Delve AI has 49,025 monthly visits, while Unlearn.AI has 17,107. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Delve AI has a month-over-month growth rate of -4.6%; Unlearn.AI has -32.5%.

### How does pricing compare?

Delve AI: Freemium. Delve AI follows a freemium model: you can start generating personas and exploring the platform for free, then move to paid plans for heavier usage, more studies and team features. Exact plan tiers and rates are listed on its pricing page, and demo calls are available for larger deployments. Unlearn.AI: Contact for Pricing. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Branded](https://openaitools.app/tool/gobranded-com) | 3,704,728 | +6.6% | Contact for Pricing | Targeted research audiences with AI-verified data quality | [.md](https://openaitools.app/tool/gobranded-com.md) |
| 2 | [Listen Labs](https://openaitools.app/tool/listen-labs) | 1,254,632 | +22.1% | Contact for Pricing | AI-moderated customer interviews that turn conversations into decisions | [.md](https://openaitools.app/tool/listen-labs.md) |
| 3 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 4 | [Upheal](https://openaitools.app/tool/upheal-io) | 347,782 | -2.1% | Freemium, Free Trial, Contact for Pricing | AI therapy notes and an AI-native EHR built for mental health professionals. | [.md](https://openaitools.app/tool/upheal-io.md) |
| 5 | [Emporia Research](https://openaitools.app/tool/emporia-research) | 270,281 | -0.6% | Contact for Pricing | Verified B2B and healthcare respondents for high-quality research | [.md](https://openaitools.app/tool/emporia-research.md) |
| 6 | [Dovetail](https://openaitools.app/tool/dovetail) | 238,937 | -5.1% | Contact for Pricing | AI-native customer intelligence platform that turns every customer conversation into context | [.md](https://openaitools.app/tool/dovetail.md) |
| 7 | [Oatmeal Health](https://openaitools.app/tool/oatmeal-health) | 40,264 | -44.9% | Contact for Pricing | AI lung cancer screening that finds eligible patients and scores every nodule | [.md](https://openaitools.app/tool/oatmeal-health.md) |
| 8 | [BioBrain Insights](https://openaitools.app/tool/biobrain-insights-mrops-platform) | 27,692 | +32.4% | Contact for Pricing | Agile MROps platform that unifies market research with AI, automation, and data quality controls | [.md](https://openaitools.app/tool/biobrain-insights-mrops-platform.md) |
| 9 | [Articos](https://openaitools.app/tool/articos) | 26,818 | -20.1% | Free Trial, Paid | AI user research platform that runs synthetic interviews and delivers a report in 30 minutes | [.md](https://openaitools.app/tool/articos.md) |
| 10 | [Versive](https://openaitools.app/tool/versive) | 20,376 | +56.8% | Freemium | Run surveys, AI interviews, and usability tests in one research workspace | [.md](https://openaitools.app/tool/versive.md) |

---
Source: https://openaitools.app/compare/delve-vs-unlearn-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
